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 c-Fos proto-oncoprotein forms AP-1
t r a n s c r i p t i o n  c o m p l e x e s  w i t h
heterodimerization partners such as c-Jun,
JunB and JunD. Thereby, it controls essential
cell functions and exerts tumorigenic actions.
The dynamics of c-Fos intracellular
distribution is poorly understood. Hence, we
have combined genetic, cell biology and
microscopic approaches to investigate this
issue. In addition to a previously
characterized basic NLS located within the
central DNA-binding domain, we identified a
second NLS within the c-Fos N-terminal
region. This NLS is non-classical and its
activity depends on transportin 1 in vivo.
Under conditions of prominent nuclear
loca l izat ion ,  c -Fos  can  undergo
nucleocytoplasmic shuttling through an active
Crm-1 exportin-independent mechanism.
Dimerization with the Jun proteins inhibits c-
Fos nuclear exit. The strongest effect is
observed with c-Jun probably in accordance
with the relative stabilities of the different c-
Fos:Jun dimers. Retrotransport inhibition is
not due to binding of dimers to DNA and
therefore to indirect effects linked to
activation of c-Fos target genes. Monomeric,
but not dimeric, Jun proteins also shuttle
actively. Thus, our work unveils a novel
regulation operating on AP-1 by
demonstrating that dimerization is crucial,
not only for active transcription complex
formation, but also for keeping them in the
compartment where they exert their
transcriptional function.
The dimeric transcription factors of the
AP-1 family control virtually all cell fates. They
play essential roles in most major physiological
processes and are involved in various
pathological situations, including tumorigenesis
(for reviews see :(1-5). Consistently, AP-1 is
controlled by a plethora of physiological stimuli
and environmental insults operating at multiple
transcriptional, post-transcriptional and post-
translational levels to prevent deleterious
expression and/or activity.
The best-studied AP-1 components are
the Fos (c-Fos, FosB, Fra-1, Fra2) and Jun (c-
Jun, JunB, JunD) proteins that dimerize via a
leucine zipper domain (LZ) and recognize their
target DNA sequences owing to an adjacent,
upstream basic DNA-binding domain (DBD)
(6). In contrast to the Jun family members, Fos
proteins cannot homodimerize. They must
heterodimerize with different partners, including
the Jun proteins, to form active AP-1 dimers.
c-Fos (for a review, see (7) is expressed
constitutively in diverse primary tumors and
cancer cell lines (3) and in certain tissues in vivo.
In most other cells, it can be rapidly and
transiently induced by many stimuli including
mitogens, cytokines, hormones and stresses (4)
to convert them into long-term responses the
nature of which depends on the cell context and
the stimulus. Not only the multiplicity of its
dimerization partners is important for c-Fos
specificity and activity, but also the many post-
translational modifications it is subjected to.
Thus, c-Fos is an unstable protein undergoing
proteasome-dependent degradation (8-11).
Proteolysis of the bulk of c-Fos is essentially
ubiquitylation-independent (12), which is also
the case for its Fra-1 relative (13), but can under
certain conditions involve ubiquitylation (14).
Moreover, c-Fos transcriptional activity, which
depends on multiple transactivation domains, is
stimulated upon phosphorylation of various
threonines in response to either oncogenic Ras
GTPases or kinases of the Erk1/2 MAPK kinase
pathway (for a review, see (15). By contrast, it is
reduced upon sumoylation at a unique lysine
(16).
One aspect of c-Fos biology that has
been poorly studied is the control of intracellular
localization. Usually, the protein predominantly
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accumulates within the nucleus (17,18). Entry
into the nucleus does not require prior LZ-
dependent heterodimerization but likely depends
on at least two nuclear localization signals
(NLS)(18,19). Thus far, only one NLS has been
characterized in details. It consists of an
arginine-rich basic motif residing within the
DBD (amino acids 139 to 160) (18). c-Fos
displays high in vitro affinity for importin β1
(Impβ1) (20), a member of the importin β
superfamily of nuclear transport receptors that
recruit protein cargoes within the cytoplasm,
address them to the nucleopore complex (NPC)
and mediate their translocation through the NPC
(21,22). More recently, a digitonin-
permeabilized cell-based in vitro assay
suggested that c-Fos nuclear transport may
rather involve two importins, one being Impβ1,
through interaction with the basic NLS, the other
being transportin 1 (TRN1), interacting with an
unidentified upstream NLS (23). In this
biochemical assay, the TNR1- and Impβ1 -
dependent pathways showed mutual exclusion
with TNR1 appearing more efficient for c-Fos
nuclear import.
c-Fos is also found cytoplasmic in
various situations. Its transport into the nucleus
depends on extra- and intracellular signals that
may be absent depending on the conditions.
Thus, in cells constitutively expressing it, c-Fos
progressively becomes exclusively cytoplasmic
within a few hours upon removal of serum from
the culture medium (17,24). Preferential
cytoplasmic localization associated with faster
turnover is also observed when endogenous c-
Fos is induced by STAT3 signaling under
conditions where the Erk5 kinase pathway is
inactivated (14). This intracellular redistribution
seems to depend, at least in part, on c-Fos
nuclear export by the Crm-1 exportin (14).
Furthermore, a fraction of c-Fos associates with
the endoplasmic reticulum to activate
phospholipid metabolism in a transcription
activity-independent manner (25). This seems
required for neurite elongation (26), suggesting a
physiological cytoplasmic role for c-Fos in
addition to its long-known nuclear one in
transcription. Finally, cytoplasmic retention of c-
Fos is reversed upon activation of cAMP-
dependent protein kinase A (17) and upon that of
p38 MAP kinases by UV irradiation (27).
The afore-mentioned observations
s u g g e s t  t h a t  a c t i v e l y  r e g u l a t e d
nucleocytoplasmic traffic may contribute to c-
Fos activity regulation. We have therefore
combined genetic, cell biology and microscopic
studies to investigate c-Fos nucleocytoplasmic
shuttling, including when the protein is
essentially nuclear, to characterize more
precisely c-Fos second NLS and to assess the
actual roles of Impβ1 and TRN1 in its nuclear
import in vivo.
EXPERIMENTAL PROCEDURES
Plasmids, clonings and mutagenesis - Cloning
and mutagenesis were performed using standard
PCR-based methods into the CMV promoter-
based pcDNA3 expression vector (Invitrogen).
c-Fos ORF were from rat and those of Jun
proteins from mouse. EGFP chimeras were
constructed using the pEGFP-C1 or the pEGFP-
N1 vectors from Clontech. The GST ORF was
recovered from pGEX-2T plasmid (Amersham).
YFP-based plasmids for bi-molecular
fluorescence complementation (BiFC)
experiments are described in Hu et al. (28).
YFP[1-154] was connected to c-Fos using the
RSIAT linker and YFP[155-238] to c-Jun and
JunB using the RPACKIPNDLKQKVMNH
peptide. pDsRed2-C1 and pDsRed-m-C1 were
from Clontech. Mouse c-Jun-Flag (29), JunD-
Flag (30), HA-HDAC4 (31) and the tethered c-
Jun~c-Fos dimer expression plasmid (32) are
CMV promoter-based vectors. JunB-Flag was
cloned in the CMV promoter-based pcDNA3
vector. GST/NLS/GFP, and GST/NLS/
GFP/NES ORF were recovered from
pR1GsvNLSF1 and pR1GsvNLSFrevNES1
(33), respectively, and cloned into pcDNA3.
Antibodies - c-Fos was immunodetected using
either the sc52 rabbit-, the sc52 goat- or the
H125 rabbit antisera. c-Jun was detected with
the sc45-, JunB with the sc46-, JunD- with the
sc74 and TRN1 with the sc6914 rabbit antisera.
All the afore-mentioned antibodies were from
Santa-Cruz Biotechnology. HA- and Flag-tagged
proteins were detected using the 3F10 rat
monoclonal anti-HA (Sigma) and the mouse
monoclonal M2 anti-Flag (Roche) antibodies,
respectively. Rabbit anti-exportin7, anti-
importin7 and anti-TRN2 antibodies were kind
gifts from Drs D. Görlich and U. Kutay. The
secondary FITC-labeled and HRP-conjugated
antibodies were from Sigma and the secondary
Alexa647- and Alexa488-labelled antibodies
w e r e  f r o m  M o l e c u l a r  P r o b e .
Immunoprecipitation were performed using the
M2 anti-Flag antibody coupled to protein A
agarose.
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Chemicals - Hoescht 33342, cycloheximide
(CHX), Hybrimax polyethylene glycol (PEG)
and leptomycin B (LMB) were from Sigma.
Paraformaldehyde was from Electron
Microscopy Sciences, Permafluor from Shandon
Immunon and complete mini protease inhibitor
cocktail tablets from Roche. CHX and LMB
were used at final concentrations of 50 µg/ml
and 20 to 100 nM, respectively.
Cells, culture and transfection - Mouse Balb/C
3T3 fibroblasts and human HeLa cells are
available from the ATCC and were grown under
standard conditions. The f10 c-fos -/- mouse
embryo fibroblast cell line (34) is a kind gift
from E. Wagner. Transfections were performed
using the calcium phosphate coprecipitation
procedure (35). Transfections were routinely
carried out using 3 µg of plasmid per 106 cells.
When necessary, 3 µg of pDsRed2 or pDsRed-
m-C1 were also co-transfected. Transfection
time was limited to 16 hours to avoid
overexpression, except for BiFC experiments
where cells were incubated for another 8 hours
at 30°C before PEG-mediated fusion to allow for
optimal renaturation of YFP.
Heterokaryon experiments - Heterokaryon
assays were essentially performed as described
by Roth et al. (36) using cells seeded on glass
coverslips. To investigate endogenous c-Fos
protein nucleocytoplasmic shuttling, Balb/C 3T3
cells were serum-deprived for 48 hours and,
then, stimulated by addition of fresh medium
containing 20% serum. 1 hour later, freshly
trypsinized HeLa cells, previously transfected
with the pDsRed2-C1 plasmid for 16 hours,
were added in presence of CHX. After another 2
hours, i.e. time sufficient for cell spreading,
coverslips were quickly rinsed in PBS (150 mM
NaCl, 10 mM Na phosphate pH7), covered with
a 50% w/v solution of PEG for 2 min, again
carefully washed with PBS and, finally,
incubated at 37°C for 1 hour in fresh medium
containing 10% serum and CHX. Cells were
then fixed and treated for microscopic
examination. To study shuttling efficiency at low
temperature, HeLa cells transfected with
appropriate expression plamids were PEG-fused
with Balb/C 3T3 cells, let at 37°C for 15 minutes
to allow completion of heterokaryon formation
and, then, placed on ice for 45 minutes before
cell fixation and microscope analysis. To study
EGFP-c-Fos and EGFP-c-Fos∆LZ shuttling
during the G0/G1 transition, f10 c-fos-/- mouse
embryo fibroblasts were stably transfected with
expression plasmids for each one of the two
proteins under the transcriptional control of a
minimal c-fos promoter containing the serum-
responsive element (SRE) and recapitulating the
transient induction of normal c- fos gene
(9,10,12,13). Transfectants were starved for 36
hours, trypsinized, stimulated by resuspension in
fresh culture medium containing 20% serum and
placed over a monolayer culture of
asynchronous HeLa cells grown on coverslips.
One hour later, i.e. a time sufficient for
transfectant attachment, cells were PEG-fused
and let for another 1 hour at 37°C in presence of
CHX before fixing and direct fluorescence
microscopy analysis. For analysis of ectopic
wild type and mutant c-Fos and c-Jun proteins as
well as that of EGFP chimeras, HeLa cells were
cotransfected with pDsRed2-C1 and the relevant
expression vector(s). 16 hours later, freshly
trypsinized Balb/C 3T3 cells were added in
presence of CHX, with or without LMB, for 2
hrs. Fusion was performed as above and cells
were incubated at 37°C for another 1 hour in the
presence of LMB, when needed, before
treatment for microscopic examination.
Localization of c-Fos at low temperature – For
the analysis of c-Fos redistribution at low
temperature, HeLa cells were transfected with
expression vectors for either EGFP/NLS/NLS or
c-Fos and, 16 hours later, placed on ice for 1
hour before fixation and microscopic analysis.
Immunofluorescence - Cells were fixed in 4%
paraformaldehyde at room temperature for 30
min, washed twice in PBS, permeabilized with
0.2% Triton X100 at room temperature for 5
minutes and, then, washed twice in PBS before
incubation in PBS containing 0.5% bovine
serum albumin (BSA) for 15 minutes. Protein
immunodetections were carried out with
optimized dilutions of primary- and FITC-,
Alexa488- and Alexa647-conjugated secondary
antibodies. Nuclei were stained using Hoescht
33342 at a 0.2 µg/ml concentration for 5 min.
Coverslips were mounted in Permafluor.
Observations were performed using either a
Leica DMRA microscope equipped with a 63X
oil lense and a coolsnap FX camera or a confocal
Leica DMR microscope equipped with a 63X oil
lense, a confocal spinning disc (Yokogawa) and
a coolsnap FX camera. Fluorescence signal
quantifications were performed using the
Metamorph software and 12 bit images.
FRAP and FLIP experiments - FRAP and FLIP
analysis were performed at 37°C with a Zeiss
LSM510 Meta microscope equipped with a
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heating chamber and a plan Apochromat 63X
water immersion lense. For EGFP fluorescence
monitoring, cells were excited with an argon
laser at a wavelength of 488 nm and emission
was collected using the 505-550 nm wavelength
bandpass filter. For DsRed2-monomer
fluorescence monitoring, cells were excited with
the 543 nm wavelength laser and emission was
collected using the 560 nm wavelength long path
filter. Before photobleaching, 5 fluorescence
intensity measurements were made over a period
of 5 minutes. For FRAP experiments, HeLa cells
were washed once with PBS, incubated with
PEG for 1 min, washed again 10 times with PBS
to remove any trace of PEG and incubated at
37°C in DMEM containing 10% serum. One
hour later, cells were co-transfected with
pDsRed-m-C1 and the plasmid of interest. 19
hours after fusion, FRAP experiments were
carried out on cells previously cultured in the
presence of CHX for 1 hour. Photobleaching
was carried out on the whole surface of one
targeted nucleus of the homopolykaryon using
the 488 nm wavelength laser at maximal power.
The bleach was of 256 µs/pixel. The recovery of
fluorescence in the bleached area was monitored
every minute. For FLIP experiments, HeLa cells
were cotransfected with the pDsRed-m-C1 for
visualization of the cytoplasm and the plasmid of
interest. 16 hours later, approximately half of the
cytoplasm of the transfected cells was irradiated
every minute for 10-15 seconds with the 488 nm
wavelength laser at maximal power with a
bleach of 25,6 µs/pixel. Nuclear fluorescence
was monitored after each bleach.
SiRNA experiments - SiRNA against Impβ1
(sc35736) and TRN1 (sc35737) were purchased
from Santa Cruz Biotechnology. The anti-TRN2
siRNA, which was a mix of two sequences (5’-
GUGGCCUCAUCCUCAAGAATT-3’ and 5’-
GCAGUUCUCUGAGCAAUUCTT-3’)  and the
anti-Imp7 (5’-GAUGGAGCCCUGCAUAUGA-
3’) siRNA were purchased from Eurogentec.
They (200 pmoles/well) were transfected in
HeLa cells (3 x 105 cells/well of 6 well plates)
using Oligofectamine (3µl/well) according to the
supplier (Invitrogen) specifications. Thirty-six
hours later, cells were transfected with the
plasmids of interest using the calcium phosphate
coprecipitation procedure (3 µg of plasmid per
35 mm culture dish). 16 hours later, they were
fixed for microscopic observation or lysed in the
RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM
NaCl, 0.02% NaN3, 0,1% SDS, 1% NP40, 0.5%
DOC, 1 Complete Mini protease inhibitor
cocktail tablet per 10 ml buffer) for
immunoblotting analysis.
 Immunoprecipitation and immunoblotting assays
- Immunoprecipitations were performed as in (16).
107 cells were lysed in 600 µl of RIPA buffer. To
immunoprecipitate Flag-tagged proteins, 200 µl of
lysates were incubated with 30 µl of anti-Flag M2
affinity gel (Sigma) for 3 hours. Lysates were then
centrifuged, supernatants collected, and pellets
resuspended in Laemmli electrophoresis loading
buffer after 5 washes. Total extracts, supernatants,
and immunoprecipitates fraction were then
submitted to immunoblotting analysis. For this,
proteins were electrotransfered on PVDF
membranes after fractionation through 12%
PAGE-SDS gels. Immunoblots were probed with
the appropriate antibodies. Quantification of
luminescence signals was performed using the
GeneGnome system from Syngene.
Cell fractionation experiments - Cell fractionation
experiments were performed as previously
described in (37). Briefly, 107 cells were scrapped
in PBS on ice, harvested by low speed
centrifugation and resuspended in 200 µl of cold
buffer A (10 mM Hepes pH 7.9, 10 mM KCl, 1.5
mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM
DTT, 1 Complete Mini protease inhibitor cocktail
tablet per 10 ml buffer). Cells were then lysed on
ice for 15 minutes by addition of 0.15% Triton X-
100 and centrifuged at 3500 rpm at 4°C for 5
minutes. The supernatants (S) contained both the
cytoplasmic and the nuclear soluble fractions.
Nuclei were then washed once in 200 µl of cold
buffer B (3 mM EDTA, 0.2 mM EDTA, 1 mM
DTT and the complete mini protease inhibitor
cocktail) and centrifuged. The centrifugation
supernatants corresponded to the wash fraction
(W). The pellets (P) corresponding to the non
soluble fraction were directly resuspended in
denaturing Laemmli electrophoresis loading
buffer. Equivalent amounts of the 3 fractions were
then submitted to immunoblotting analysis. An
anti-Phax monoclonal antibody (mAb 8G5; gift of
Dr. E. Bertrand) was used to characterize the
soluble nuclear fraction and an anti-topoisomerase
I one (gift of Dr J. Tazi) was used to characterize
the insoluble one (see (16).
RESULTS
c-Fos shuttles between the nucleus and the
cytoplasm -  We f i r s t  t e s t ed  the
nucleocytoplasmic shuttling activity of c-Fos
under conditions of prominently nuclear steady-
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state localization. This was achieved in classical
heterokaryon assays in which a donor cell
expressing the protein of interest is fused to an
acceptor cell not expressing it in the presence of
polyethylene glycol (PEG). The experiment was
performed in the presence of cycloheximide
(CHX) to prevent bias possibly generated by
newly synthetized proteins. In case of shuttling,
the studied protein is reimported indifferently in
both donor and acceptor cell nuclei, after exit
from the donor nucleus.
Transient induction by growth factors in
cells reentering the cell cycle is one of the best-
characterized physiological situations to study c-
Fos. Therefore, quiescent Balb/C 3T3 mouse
embryo fibroblasts were stimulated by serum to
induce endogenous c-Fos whose transient
expression peaks by 1-2 hours post-stimulation
and returns to basal level 4-6 hours later when
cells traverse the G0/G1 transition (38). They
were then fused to asynchronous human HeLa
cells expressing an ectopic red fluorescent
protein (Ds-Red) for visualization of
heterokaryons. c-Fos distribution was monitored
by indirect immunofluorescence 1 hour post-
fusion, DNA staining with Hoescht 33342
permitting easy discrimination of human and
mouse nuclei. Figure 1Aa shows a clear
accumulation of c-Fos in human acceptor nuclei.
Similar results were obtained in the reverse
experiment when serum-stimulated HeLa cells
were used as donors and Balb/C fibroblasts as
acceptors (not shown). Thus, endogenous c-Fos
can shuttle under physiological conditions of
expression.
We then expressed an exogenous c-Fos
in asynchronous HeLa cells, which is a situation
mimicking constitutive nuclear expression found
in certain tissues and tumors, and investigated c-
Fos shuttling activity. To avoid biases linked to
overexpression, transfection was optimized to
ensure a c-Fos accumulation level comparable to
that of the endogenous protein induced by serum
stimulation (not shown). One hour post-fusion
with asynchronous Balb/C fibroblasts, c-Fos was
found in both human and mouse nuclei of
heterokaryons (Fig. 1Ab), indicating ability to
shuttle in this setting. Heterocaryon formation is
not synchronous but spread over time following
PEG treatment, which makes impossible to
precisely measure the half-time for c-Fos return
to the cytoplasm. However, quantification of c-
Fos transfer from HeLa to Balb/C cell nuclei
allowed  to estimate  c-Fos half-return time to
the cytoplasm to be less than 30 minutes. This
value is much less than the 2,5 hour half-life of
c-Fos in exponentially growing Balb/C and
HeLa cells (10,12) indicating the possibility for
c-Fos to undergo several rounds of
nucleocytoplasmic shuttling during its lifespan.
Heterokaryon assays may lead to
misinterpretation on actual physiological protein
shuttling ability because PEG also induces
transient endoplasmic reticulum disruption (39),
which results in release of calreticulin that can
operate as an illegitimate exportin for
approximately 1 hour (39). To exclude this
possibility for c-Fos, we first used a
Fluorescence Recovery After Photobleaching
(FRAP) approach. As these experiments on
living cells required the use of fluorescent
proteins, we resorted to a chimera (EGFP/c-Fos)
in which c-Fos was C-terminally fused to
enhanced green fluorescent protein (EGFP).
Previous work (10) has shown that, in contrast to
EGFP, which diffuses freely within the whole
cell due to its small size and absence of both
NLS and NES (Nuclear Export Signal), EGFP/c-
Fos displays the typical nuclear localization with
nucleolar exclusion of c-Fos (see Fig. 4).
Moreover, this chimera keeps other properties
such as transcriptional activation of an AP-1-
dependent reporter gene and Erk1/2 pathway-
inhibitable proteasomal degradation, which
validates its use in a number of settings.
Homopolykaryons formed of PEG-fused HeLa
cells were transfected to express EGFP/c-Fos.
Twenty hours later, i.e. a time much longer than
that sufficient for ER restoration (39), one of the
EGFP/c-Fos-positive homopolykaryon nuclei
was photobleached after protein synthesis arrest
by CHX. Recovery of nuclear fluorescence, due
to entry of EGFP/c-Fos originating from the
non-FRAPped nuclei, was monitored as a
function of time. A typical experiment is
presented in Figs 1Ba and 1Bc. Progressive
recovery of the fluorescence in the bleached
nucleus correlated with a concomitant and
proportional decrease of fluorescence in the non-
bleached nucleus of an homodikaryon and
fluorescence equilibrium between the two nuclei
was reached by 2 hours. This process was
specific as no, or very low, fluorescence
recovery was observed 2 hours post-bleach when
a control non-shuttling GST/NLS/GFP protein
made up of gluthatione-S-transferase (GST),
NLS of the SV40 virus LT antigen and green
fluorescent protein (GFP) (33) was analyzed
(Fig. 1Bb and 1Bd).
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Next, a Fluorescence Loss Induced after
Photobleaching (FLIP) assay further
demonstrated that membrane fusion was not
responsible for induction of c-Fos nuclear export
and excluded bias possibly due to protein
synthesis inhibition as outcomes were identical
whether CHX was present or not. Individual
HeLa cells expressing either the non-shuttling
nuclear GST/NLS/GFP, as a negative control, or
EGFP chimeras with C-terminal (EGFP/c-Fos)
or N-terminal (c-Fos/EGFP) c-Fos extensions
were photobleached at the level of their
cytoplasm every minute for 40 minutes to
inactivate the fluorescence of chimeras returning
in this compartment before measurement of
residual nuclear fluorescence. Importantly, the
experiment duration was chosen to avoid bias
possibly due to protein degradation : EGFP/c-
Fos half-life is more than 2.5 hours and those of
c-Fos/EGFP and GST/NLS/GFP are much
longer (10), meaning that no detectable
abundance decrease occurred during the FLIP.
Loss of fluorescence was two-fold higher in the
case of EGFP/c-Fos (Fig. 1C) and c-Fos/EGFP
(not shown) than for GST/NLS/GFP, which was
consistent with the nucleocytoplasmic shuttling
capability provided by the c-Fos moiety of the
two EGFP/chimeras. Noteworthy, cytoplasmic
photobleaching inactivates the fluorescence of
EGFP chimera exiting the nucleus as well as that
of newly synthetized proteins. It is, nevertheless,
unlikely that the latter population of molecules
has impinged on our data as (i) the long life span
of all chimera implicates that neosynthetized
proteins constituted only a small fraction of the
molecules analyzed during the experiment and
(ii) addition of CHX did not interfere with the
final outcomes of the experiments (Fig. 1C).
Thus, c-Fos, even under condition of
predominant nuclear localization, can undergo
nucleocytoplasmic shuttling.
N-terminal domain NLS delineation - Various c-
Fos deletion mutants and EGFP chimeras were
then studied in HeLa cells to identify the regions
of c-Fos involved in nuclear import. Our main
results were :
- (i) We found no evidence for an NLS
located C-terminally of the DBD, i.e. neither
within the LZ (amino acids 160-200) nor within
the C-terminal domain (amino acids 200-380)
(Fig. 2A), as neither LZ- (c-FosΔ163-196
mutant) nor C-terminal domain (c-Fos[1-196])
deletion detectably altered c-Fos nuclear
localization (Fig.2B). Moreover, a truncated c-
Fos mutant composed of only half of the DBD,
the LZ and the C-terminal domain (c-Fos[150-
380]) distributed evenly within the cell (Fig.2B).
Consistently, neither the fusion of the LZ
(EGFP/c-Fos[160-200] chimera) nor that of the
C-terminal domain (EGFP/c-Fos[200-380])
affected the naturally homogenous intracellular
distribution of EGFP (Fig.2B).
- (ii) We confirmed the presence of an
NLS within the DBD and showed the presence
of a second NLS in the N-terminal domain.
Indeed, fusion of the DBD (EGFP/c-Fos[140-
159]) or of the N-terminal moiety (c-Fos[1-
139]/EGFP) to EGFP, entailed nuclear
accumulation of the two chimeras (Fig. 2Cg,
2Ch, 2Dg and 2Dh). Moreover, deletion of either
the N-terminal domain (c-FosΔ1-139) or the
DBD (c-FosΔ140-159) only led to partial
cytoplasmic redistribution of c-Fos (30-35% and
25-30 % cytoplasmic accumulation,
respectively, as quantified by indirect
immunofluorescence in a confocal plane) (Fig.
2Cb, 2Cc, 2Db and 2Dc). This indicated that
quantitative nuclear accumulation of c-Fos
depends on the combined action of both NLS.
- (iii) We mapped an element with
autonomous NLS activity between amino acids
90 and 139 but we could not detect another
element with comparable activity upstream of
amino acid 90. Supporting this conclusion, c-Fos
amino acids 90-139 (c-Fos[90-139]/EGFP
chimera) could drive EGFP in the nucleus,
whereas amino acids 1-49 (not shown) or 1-90
(c-Fos[1-90]/EGFP) could not (Fig.  2Cj, 2Ci,
2Dj and 2Di). Two observations also showed
that full activity of this N-terminal moiety NLS
depends on another upstream element in the c-
Fos context. First, deletion of only the N-
terminal 89 (c-FosΔ1-89 mutant; not shown) or
49 amino acids (c-FosΔ1-49 mutant) was as
efficient as the removal of the whole N-terminal
moiety (i.e. amino acids 1-139) for inducing
partial (30-35 %) cytoplasmic redistribution of
c-Fos (Fig. 2Cc, 2Cd, 2Dc and 2Dd). As this
redistribution was comparable to that of the c-
Fos∆1-139 mutant that still harbors the DBD
NLS, this suggested complete loss of activity for
the NLS located between amino acids 90 and
139 in c-FosΔ1-49 and c-FosΔ1-89. Second, the
deletion of both amino acids 1-49 and the DBD
(c-FosΔ1-49Δ140-159 mutant) led to an even
distribution of c-Fos throughout of the cells.
This was indicative of total loss of NLS activity
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by the amino acids 90-139 domain that was left
intact in c-FosΔ1-49Δ140-159 (Fig. 2Ce and
De). Moreover, the latter data also indicated the
absence of a third NLS in c-Fos.
Transportin 1 contributes to N-terminal NLS-
mediated c-Fos nuclear import in vivo - In vitro,
Impβ1 and TRN1 can mediate DBD- and N-
terminal NLS-dependent c-Fos nuclear transport,
respectively (23). We therefore addressed
whether this was also the case in vivo.
Cytoplasmic versus nuclear accumulation of
both c-Fos deletion mutants and EGFP chimeras
harboring only one of the two NLS were
consequently quantified in HeLa cells subjected
to RNA interference against different importins.
Not only Impß1 and TRN1 were considered, but
also TRN2, as this latter import receptor displays
high similarity and partial functional redundancy
with TRN1 (40,41). As a control, we used Imp7
depletion which, at least in vitro, has been
shown not to participate in c-Fos nuclear import
(23).
c-Fos[1-139]/EGFP/GST is a chimeric
protein made up of the N-terminal moiety of c-
Fos, EGFP and GST. Due to its molecular
weight (80 kDa) and ability to dimerize owing to
its GST part, it cannot diffuse passively through
the nuclear pore, which permits accurate
monitoring of c-Fos N-terminal NLS activity.
Under control conditions, 44% of cells expressed
less than 30% of c-Fos[1-139]/EGFP/GST in the
cytoplasm and 55 % of them between 30 to 50%
(Fig. 3A and B). No significant change in c-Fos
distribution was observed in the presence of
siRNAs against TNR2, Impβ1 or Imp7 (Fig. 3
B) despite an effective reduction (60-70% for
TRN2 and 90% for Impβ1 and Imp7) in nuclear
import receptor abundance (Fig. 3C). By
contrast, transfection of anti-TRN1 siRNAs
shifted the accumulation of c-Fos[1-
139]/EGFP/GST towards a predominant
cytoplasmic localization in 40% of the cells with
more than 50% of the protein within the
cytoplasm (Fig. 3B). Interestingly, RNA
interference against both TRN1 and TRN2
increased neither the percentage of c-Fos[1-
139]/EGFP/GST within the cytoplasm nor the
fraction of cells with more than 50% of the
protein within the cytoplasm (Fig. 3B). This
suggested that TRN1 and TRN2 do not
cooperate for N-terminal NLS-mediated nuclear
transport of c-Fos. This was an important
verification, as the anti-TNR1 siRNA alone led
to a reproducible increase in TNR2 level (Fig.
3C) that might have compensated for the
reduction in TRN1 activity. Strengthening the
idea of TRN1 involvement in N-terminal NLS-
dependent c-Fos nuclear transport, similar data
were obtained when the cytoplasmic versus
nuclear distributions of the DBD-lacking c-
FosΔ140-159 mutant and the EGFP/c-FosΔ140-
159 chimera were investigated (not shown).
Next, as Impβ1 was shown to interact
with c-Fos DBD in vitro (23), we investigated
whether Impß1 is involved in basic NLS-
mediated c-Fos nuclear import in vivo using two
chimeras : EGFP/c-Fos[140-200], involving the
b-Zip domain, and EGFP/c-Fos[140-380],
containing the bZip + the c-Fos C-terminal
domain. No increase in cytoplasmic localization
was observed in any of our multiple siRNA
transfection experiments. Absence of effect
must, however, be interpreted cautiously.
Although the amount of the importin was
reduced by 90 %, it cannot be excluded that its
residual level was still sufficient for nuclear
transport of c-Fos-EGFP chimeras. This
possibility was to be considered as attempts to
obtain stronger repression by repeated
transfections and/or use of increasing amounts of
anti-Impβ1 siRNA repeatedly led to dramatic
cell death whereas apoptosis was limited under
the conditions used in experiments such as that
presented in Fig. 3. Similar to Impβ1, no effect
was observed for Imp7 and TRN2 knockdowns
(see Discussion).
Thus, whereas we cannot conclude on
the role of Impβ1, we show a clear role for
TRN1 in N-terminal NLS-mediated nuclear
import of c-Fos in vivo.
c-Fos exits the nucleus independently of Crm1 -
As (i) various shuttling transcription factors are
exported from the nucleus by the leptomycin B
(LMB)-sensitive Crm-1 exportin (42), (ii) c-Fos
contains three motifs showing similarities with
NES recognized by Crm1 (43) and (iii) c-Fos
cytoplasmic accumulation in cells with activated
STAT3 and inactive Erk5 is inhibited by LMB
(14), we tested Crm-1 implication in c-Fos
nuclear export in heterokaryon experiments. Our
results showed that addition of LMB, up to a
concentration of 100 nM, could not inhibit c-Fos
shuttling whereas under the same experimental
conditions the shuttling of HDAC4 (44) and that
of the chimeric protein GST/NLS/GFP/NES, a
GST/GFP chimera containing both the SV40 LT
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antigen NLS and the LMB-sensitive HIV Rev
NES (43), were fully blocked (Fig. 4). Thus, in
cells predominantly accumulating c-Fos in the
nucleus, c-Fos nuclear export does not depend
on the classical LMB-sensitive CRM1 pathway.
It was then important to ask whether c-
Fos is exported into the cytoplasm passively or
via an active mechanism. To this aim, we first
conducted heterokaryon assays under conditions
where active nuclear import and export are
inhibited by shift to low temperature whereas
passive diffusion through the NPC is not (45,46).
In these experiments, c-Fos shuttling was
compared to that of EGFP/NLS/NLS as the latter
protein (i) is efficiently imported into the
nucleus, due to the presence of a duplicated
SV40 LT antigen NLS, (ii) it is not actively
exported back to the cytoplasm, due to the
absence of an NES, (iii) it can diffuse passively
between the nucleus and the cytoplasm because
of its relatively small size and (iv) its size is
comparable to that of c-Fos. Transfected HeLa
cells expressing either c-Fos or EGFP/NLS/NLS
were PEG-fused to Balb/C 3T3 cells, let at 37°C
for 15 minutes to allow completion of
heterokaryon formation and, then, either
incubated on ice or at 37°C (controls) for
another 45 minutes before cell fixation and
microscope analysis. At the end of the
experiment at 37°C, EGFP/NLS/NLS was
exclusively found in donor and acceptor nuclei
with no cytoplasmic signal as active nuclear
import largely dominates over passive leakage of
the protein out of the nucleus (not shown). In
contrast, at 0°C, EGFP/NLS/NLS was found
distributed between the nuclei and the cytoplasm
in the majority of heterokaryons because its
propensity to diffuse throughout the cell could
no longer be compensated by reimport into the
nucleus (Fig. 4B). In the case of c-Fos, shuttling
activity (Fig. 1) was confirmed at 37°C with
equal labelling of donor and acceptor nuclei (not
shown). In contrast, at 0°C, the protein was
essentially found within the donor nuclei of
nearly all heterokaryons with only low
fluorescence signals in the acceptor ones (Fig.
4B). This indicated that, at low temperature,
passive diffusion of c-Fos out of the nucleus is
poorly efficient. In fact, it is very likely that the
low labelling of acceptor nuclei largely resulted
from active retrotransport during the 15 minutes
required for completion of heterokaryon
formation after PEG treatment. Strengthening
our conclusion, EGFP/NLS/NLS largely
redistributed towards the cytoplasm in most
transfected cells (95%)  upon simple chilling of
cells owing to its diffusion ability whereas c-Fos
localization was hardly affected as it remained
exclusively nuclear in 80% of transfected cells
and predominantly nuclear in the other 20%
(Fig. 4C).
Heterodimerization with c-Jun negatively
regulates c-Fos shuttling - As active AP-1
complexes are dimeric, we then asked whether
heterodimerization with c-Jun could impact on
c-Fos nuclear export. To this aim, we monitored
nucleocytoplasmic shuttling under conditions of
forced or impaired dimerization.
First, we assessed whether c-Jun itself
could shuttle, when transfected alone, and affect
c-Fos shuttling in co-transfection experiments.
This was tested in heterokaryon assays.
Importantly, the two proteins were expressed
using identical amounts of similar CMV
promoter-based vectors. As c-Jun is slightly
more stable than c-Fos and as c-Fos:c-Jun
heterodimer formation is favored over that of c-
Jun:cJun homodimers (6), this ensured a
significant excess of c-Jun over c-Fos and
quantitative engagement of the latter protein in
c-Jun:c-Fos dimers as shown in co-
immunoprecipitation experiments (Fig. 5A).
Heterokaryon assays showed that c-Jun
transfected alone shuttles very poorly compared
to c-Fos when transfected alone (Fig. 5B).
Moreover, its expression reduced the shuttling of
c-Fos by 3-fold whereas c-Fos did not affect c-
Jun shuttling in co-transfection experiments
(Fig. 5B). Two observations strengthened the
notion of c-Fos shuttling inhibition by c-Jun.
First, cytoplasmic photobleaching in FLIP
experiments showed that ectopic c-Jun slowed
down EGFP/c-Fos return to the cytoplasm (Fig.
5C). Second, 24 hours after PEG-induced
formation of HeLa cell homopolykaryons,
nuclear fluorescence of EGFP/c-Fos was not
recovered in the presence of c-Jun 2 hours after
nuclear FRAP while almost complete recovery
was seen in its absence (Fig.  5D).
We then addressed whether inhibition of
c-Fos shuttling was due to physical association
with c-Jun or to possible indirect effects of the
latter protein. To this aim, we analyzed the
behavior of a dimerization-deficient mutant of c-
Fos (47) in heterokaryon experiments. This
mutant (c-FosVAV) shuttled similarly to wild
type c-Fos transfected alone but its shuttling
activity was not slowed down by the presence of
co-transfected wild type c-Jun (Fig. 5E).
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Moreover, wild type c-Fos shuttling was not
inhibited by the presence of a dimerization-
deficient LZ-less c-Jun mutant (c-Jun∆LZ) (Fig.
5F). Taken together, these data indicate that
inhibition of c-Fos shuttling is primarily due to
physical association with c-Jun. Interestingly, in
contrast to wild type c-Jun, the non-dimerizable
c-Jun∆LZ mutant shuttled efficiently in
heterokaryon assays (Fig. 5F). This suggests that
homodimerization also prevents efficient c-Jun
shuttling.
As c-Fos and c-Jun undergo dynamic
and rapid association and dissociation cycles in
vivo (38), we then tested whether stabilizing
d imer i za t ion  cou ld  fu r the r  l imi t
nucleocytoplasmic shuttling. This was done
using a "tethered dimer" (c-Jun~c-Fos)
displaying the essential functional and biological
properties of the natural c-Jun:c-Fos dimer in
various settings (32). In this chimera, the c-Fos
and c-Jun moieties are brought together within
the same molecule by a flexible peptide linker.
Because intramolecular interactions are favored
over intermolecular ones with other LZ-
harboring proteins, this ensures both specific and
stronger interactions between c-Fos and c-Jun. In
heterokaryon assays, the shuttling efficiency of
this chimera was 10- to 15-fold less than that of
c-Fos alone and 3- to 6-fold less than that of c-
Fos in the presence of ectopic c-Jun (Fig.  5G).
Taken with the afore-mentioned data, this
indicated that LZ-mediated dimerization is
crucial for inhibition of, not only the shuttling of
c-Fos, but also that of c-Jun.
Finally, as dimerization of c-Fos and c-
Jun may be followed by recognition of genomic
AP-1 motifs in transfected cells, we assessed
whether inhibition of shuttling was primarily due
to dimerization or to binding to DNA. It is of
note that the latter may possibly be followed by
target gene transcription activation and, thereby,
indirect retrocontrol of the protein localization.
As a c-Fos DNA-binding-defective mutant (c-
FosVV) (48) behaves as c-Fos in heterokaryon
assays performed both in the presence and in the
absence of c-Jun (Fig. 5H), the primary reason
for inhibition of c-Fos shuttling is dimerization
with c-Jun and neither recognition of target
DNA sequences nor indirect effect resulting
from target gene activation.
Then, we asked whether inhibition of c-
Fos export upon heterodimerization with c-Jun
was simply due to NES masking or to
association with nuclear components/structures.
To achieve this, c-Fos intranuclear distribution
in the presence or in the absence of c-Jun was
addressed in cell fractionation experiments of
transfected HeLa cells in the presence of the
mild detergent Triton X100 as described
elsewhere (16). This allowed to isolate (i) a
fraction containing cytoplasmic and the soluble
nuclear proteins (S), (ii) an insoluble fraction
containing both the chromatin and the nuclear
matrix (P) and a "wash fraction" (W) containing
the proteins loosely attached to the insoluble
components of the nucleus. The data presented
in Fig. 5I show that c-Fos is predominantly
soluble in the absence of c-Jun and
predominantly insoluble in its presence. Thus,
retention of c-Fos within the nucleus is unlikely
to result from simple NES masking by c-Jun but
rather from association with nuclear
structure/components it cannot associate with
alone.
The above experiments being conducted
in transient transfection assays of exponentially
growing cells, we next wished to investigate the
effect of dimerization on c-Fos shuttling activity
in a more physiological situation. To achieve
this, we turned again to re-entry of quiescent
cells into the cell cycle, as c-Fos dimerizes with
the various endogenous Jun proteins expressed
under these conditions (49). To avoid
interference with endogenous c-Fos, the
experiments were conducted in f10 cells which
are mouse embryo fibroblasts derived from mice
KO for c-fos gene (34). These cells were stably
transfected with vectors (i) expressing either
EGFP-c-Fos or its non dimerizable variant
EGFP-c-FosΔLZ and (ii) recapitulating the
transient expression of the normal c-fos gene
upon stimulation by serum owing to a minimal
serum-responsive element-containing c-fos
promoter and the c-fos 3'UTR containing the
major mRNA destabilizer (Fig. 6A; see
(9,10,12,13) for more details). Importantly,
similar levels of the two chimeras were induced
in the selected transfectant populations as
assayed by immunoblotting (not shown), which
ruled out possible biases linked to differences in
protein abundance. The shuttling efficiencies of
the two EGFP-c-Fos chimera were then
compared in heterokaryon assays made between
serum-stimulated f10 transfectant and
asynchronous HeLa cells. The data presented in
Fig. 6B and 6C show that EGPF-c-Fos∆LZ
shuttles twice more efficiently than EGFP-c-Fos
during the G0/G1 transition, as estimated from
lower fluorescence intensity in acceptor nuclei
for the latter protein. This supports the idea that
 by guest on July 16, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
c-Fos nucleocytoplasmic traffic
10
heterodimerization also exerts a negative effect
on c-Fos shuttling under physiological
conditions of expression.
JunB and JunD are less efficient at inhibiting c-
Fos shuttling than c-Jun - Heterokaryon assays,
then, showed that both JunB and JunD are more
efficient at nucleocytoplasmic shuttling than
wild type c-Jun when transfected alone (Fig.
7A). They were also less efficient at inhibiting c-
Fos return into the cytoplasm (Fig.  7B). This
was not due to intrinsic inability to dimerize
with c-Fos as co-immunoprecipitations showed
quantitative association between c-Fos and the
two Juns (Fig. 7C). Co-immunoprecipitations,
however, give steady-state indications but none
on dedimerization/redimerization kinetics. As
affinities of JunB and JunD for c-Fos are lower
than that of c-Jun (6,50), dedimerization occurs
more frequently in the case of the former two
proteins, which may increase c-Fos availability
for nuclear export. We therefore tested whether
forcing dimerization with JunB could inhibit c-
Fos nuclear export. Appropriate tethered dimers
with fully characterized phenotype not being
available, we used a Bimolecular Fluorescence
Complementation (BiFC) assay (Hu et al.,
2002), in which the N-terminal moiety of the
fluorescent YFP protein was N-terminally fused
to c-Fos (YFP[1-154]/c-Fos) whereas its C-
terminal moiety was N-terminally fused to JunB
(YFP[155-238]/JunB). Neither YFP[1-154]/c-
Fos nor YFP[155-238]/JunB fluoresces by itself
and the two halves of YFP cannot reassociate on
their own. By contrast, LZ-mediated
heterodimerization of c-Fos and JunB triggers
YFP reformation, which is followed by both
fluorescence reemission and stabilization of the
dimer (28). In heterokaryon assays, fluorescent
heterodimers formed by YFP[1-154]/c-Fos and
YFP[155-238]/JunB shuttled inefficiently with
hardly detectable signals in acceptor cells (Fig.
7Da). Similar results were obtained, in parallel,
with YFP[1-154]/c-Fos and a YFP[155-238]-c-
Jun chimera (Fig. 7Db).
Thus, JunB and JunD are shuttling
proteins capable of inhibiting c-Fos nuclear
export, albeit less efficiently than c-Jun.
DISCUSSION
The present study refines our
understanding of c-Fos transport into the nucleus
and shows that c-Fos, as well as other AP-1
family proteins, undergoes regulated
nucleocytoplasmic shuttling even under
conditions of predominant nuclear localization.
Nuclear import of c-Fos - Here, we have
localized the second c-Fos NLS within the N-
terminal domain and shown that the combined
action of the two NLSs is required for
quantitative c-Fos nuclear accumulation. Several
lines of evidence suggest a complex and
conformation-dependent activity for the N-
terminal NLS. Firstly, amino acid sequence
examination excludes the presence of a classical
short, lysine- or arginine-rich NLS in c-Fos N-
terminal moiety. Secondly, EGFP chimera
analyses indicate an NLS with autonomous
activity between amino acids 90 and 139, but
none between amino acids 1 to 89. This
observation is consistent with the fact that amino
acids 111-124 are necessary for in vitro binding
of TRN1 to c-Fos (23). Thirdly, loss of activity
of the 90-139 region NLS is observed upon
deletion of c-Fos N-terminal 49 amino acids as
shown by the even nucleocytoplasmic
distribution of c-FosΔ1-49Δ140-159. The
simplest explanation for this is that elements
located within the N-terminal amino acids
contribute to the structuration of c-Fos N-
terminal moiety and, thereby, accessibility of the
90-139 NLS-carrying region. Precise molecular
characterization of this NLS may require solving
the crystal structure of a complex made up of c-
Fos[1-139] and the cognate karyopherin in
addition to further genetic experiments such as
those presented here.
Partial cytoplasmic accumulation of a c-
Fos mutant deleted of amino acids 160-380 in a
fraction of transfected Cos-1 cells has led others
to propose an NLS activity in c-Fos C-terminal
moiety (19), which neither us nor Tratner and
Verma (18) could confirm. Cell-type specific
effects may explain this discrepancy. Whatever
the case, the activity of this third NLS, if any, is
poor (19) as compared to those contained in the
DBD and the N-terminal domain (18).
Others proposed that heterodimerization
is a prerequisite for efficient c-Fos nuclear
import. This conclusion was based on cell
microinjection experiments showing that c-Fos
cannot enter the nucleus unless c-Jun is co-
expressed (51). This is in apparent contradiction
with the following observations. Firstly, when a
c-fos vector is transfected in the absence of any
Jun expression plasmid, numerous laboratories
have described nuclear accumulation of c-Fos,
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whatever the cell context used. Secondly, a LZ-
less c-Fos accumulates quantitatively within the
nucleus (18). Thirdly, EGFP- (this work) or
chicken pyruvate kinase (18) chimeras harboring
one, or the two, c-Fos NLS, but not the LZ, also
efficiently enter the nucleus. Fourthly, in co-
transfection experiments, a NLS-less c-Jun
principally localizes within the cytoplasm
whereas c-Fos essentially accumulates in the
nucleus (data not shown) even though the two
proteins have kept their ability to dimerize via
their LZ. One possibility to reconcile all of these
observations is to consider the differences in
experimental conditions. In all experiments
where c-Fos accumulates in the nucleus
independently of dimerization with c-Jun, cells
were cultured in the presence of mitogens
whereas the microinjections were carried out in
the presence of staurosporine, which inhibits
various kinases. As c-Fos nuclear transport is
dependent on extracellular signals relayed by
various intracellular signaling cascades (see
Introduction), it is possible that nuclear transport
of c-Fos is inhibited by this drug and that
dimerization with c-Jun permits to overcome this
inhibition.
Our attempts to define the in vivo
contributions of different nuclear import
receptors for c-Fos clearly demonstate that
TRN1 has a major function for the NLS located
in the N-terminal region. This result is consistent
with the in vitro data of Arnold et al. (23). The
contribution of the other importins to c-Fos
nuclear import in vivo remains unclear. In the
limit of their sensitivity, our siRNA experiments
do not favor an implication of TRN2 meaning
that c-Fos nuclear transport would depart from
that of other proteins, such as HnRNPA1 and
HuR (40,41), for which TRN1 and TRN2 are
redundant, at least in in vitro assays. For
knockdown of Impß1, we did not observe any
effect on c-Fos nuclear import mediated by the
basic NLS residing in the DBD. However,
complete depletion of Impß1 is lethal to cells.
Therefore, the remaining low levels of residual
Impß1 might have been sufficient for nuclear
import of c-Fos under our experimental
conditions. Moreover, it has recently been
demonstrated that some cargoes access multiple
import pathways using the same NLS to interact
with different transport receptors (52), indicating
redundancy and, thereby, limits of in vivo siRNA
approaches.
Nuclear export of c-Fos - Our work adds another
layer of complexity to the regulation of c-fos
gene as it indicates that c-Fos protein undergoes
nucleocytoplasmic shuttling, even under
condition of predominant nuclear localization,
and has sufficient time in its lifespan to undergo
several rounds of nuclear import and export.
Moreover, taken with Sasaki et al.'s observation
(14) that c-Fos induced by STAT3 in the
presence of inactivated Erk5 accumulates in the
cytoplasm due (at least in part) to active nuclear
export, it indicates that there exist several
mechanisms for cytoplasmic return of c-Fos for
at least two reasons. Firstly, contrasting with
LMB-sensitive retrotransport of c-Fos in Sasaki
et al's experiments, c-Fos nuclear export was
independent of Crm-1 under our experimental
conditions. Importantly, return into the
cytoplasm in the latter case depends on active
transport rather than on passive diffusion as
shown by both the absence of cytoplasmic
redistribution of c-Fos in chilled cells and lack
of shuttling activity in heterokaryon experiments
conducted at low temperature. Secondly, none of
the many other c-Fos mutants and EGFP
chimeras we have analyzed (this work and data
not shown) showed preferential or exclusive
cytoplasmic accumulation. This prevented any
precise NES characterization, including at the
level of the amino acids 223-232 domain whose
integrity is required for cytoplasmic return in
Sasaki et al.'s experiments. Nevertheless, the
possibility of an NES in the [90-139] region has
to be considered. On one hand, c-Fos[90-
139]/EGFP (as well as c-Fos[1-139]/EGFP)
partially accumulates within the cytoplasm and,
on the other hand, this region is crucial for
interaction with TRN1, many substrates of
which are shuttling proteins with overlapping
signals for nuclear import and export (53,54).
Moreover, Crm1-independent export signals
have recently been described (55).
Another important point of our study is
inhibition of c-Fos nuclear export by the Jun
proteins as we show that dimerization is crucial,
not only for the formation of active AP-1
transcription complexes, but also for keeping
them in the nucleus where they play their
transcriptional parts. At this stage of our
investigations, the biological reason of c-Fos
return into the cytoplasm remains unclear. A
first possibility is that monomeric c-Fos may be
more efficiently degraded in the cytoplasm than
in the nucleus. This would be in line with the
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observations that (i) cytoplasmic c-Fos in serum-
deprived cells is more unstable than nuclear c-
Fos in cells cultured with serum (17) and (ii)
cytoplasmic localization of c-Fos upon induction
by STAT3 in the presence of inactivated Erk5
correlates with protein destabilization (14).
Other possibilities, such as reloading of c-Fos
with transcriptional co-activators or post-
translational modifications in the cytoplasm or,
alternatively, retrocontrol of c-fos  mRNA
translation by monomeric protein in excess will
also have to be considered. Addressing this issue
would require nuclear shuttling-deficient c-Fos
mutants. Unfortunately, none of the many
variants we have generated showed these two
properties, which hampered this analysis.
Nuclear retention of c-Fos by c-Jun is
primarily due to physical association via the LZ
and neither to binding to DNA nor to indirect
effects resulting from gene activation by c-
Fos:c-Jun dimers. Moreover, our cell
fractionation experiments indicate that inhibition
of nuclear export is not due to simple masking of
c-Fos NES but rather to the fact that c-Jun favors
a s s o c i a t i o n  w i t h  i n t r a n u c l e a r
components/structures. Further work will aim at
identifying them. c-Fos shuttling is, however,
not totally inhibited by an excess of c-Jun
whereas both c-Jun:c-Fos dimers stabilized in
BiFC assays and the tethered c-Jun~c-Fos
molecule, showed inefficient shuttling activity
under the conditions used. As AP-1 dimers
constantly dissociate and reassociate in living
cells (6,38), these data suggest that basal
shuttling of c-Fos in the presence of c-Jun
concerns monomeric c-Fos and simply reflects
de-dimerization of AP-1 dimers within the
nucleus.
Interestingly, the various Jun proteins
show differential ability to retain c-Fos in the
nucleus, the effect of c-Jun being the strongest.
Recent thermal denaturation studies of bZip
dimers from the different Fos and Jun proteins
have shown that c-Fos:JunB, c-Fos:JunD,
JunB:JunB and JunD:JunD dimers are much less
stable than c-Fos:c-Jun and c-Jun:c-Jun ones
(50). It is therefore worth noting that JunB and
JunD shuttle more efficiently than c-Jun when
transfected alone and retain c-Fos in the nucleus
less efficiently than c-Jun in co-transfection
assays. This further supports the idea that
Fos:Jun dimer stability may be the primary
factor determining c-Fos return rate into the
cytoplasm.
In conclusion, we report here that
monomeric c-Fos can undergo active
nucleocytoplasmic shuttling. Nuclear export is,
however, inhibited upon dimerization with Jun
proteins, the consequence of which is to
maintain functional AP-1 complexes within the
nucleus. This situation is reminiscent to that of
the ATF2 bZIP transcription factor whose
nuclear retention by c-Jun has recently been
reported (56). The degree of inhibition of c-Fos
nuclear export depends on the Jun
heterodimerization partner, which adds another
layer of complexity to the finely tuned regulation
of the family of AP-1 transcription complexes.
At first approximation, inhibition efficiency
correlates with the relative stabilities of the
different Jun:c-Fos dimers, at least as deduced
from in vitro thermal denaturation studies of
their bZip. As post-translational modifications
can interfere with AP-1 dimer formation (6), an
important question will, therefore, be to
determine whether intracellular signaling can
modulate c-Fos nucleocytoplasmic dynamics
under physiological and/or pathological
situations.
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FIGURE LEGENDS
Fig. 1 : c-Fos is a shuttling protein. (A) Endogenous and transfected c-Fos nucleocytoplasmic
shuttling in heterokaryon assays. In (Aa), serum-starved Balb/C 3T3 cells were stimulated by 20%
serum to allow endogenous c-Fos expression. 1 hour later, HeLa cells expressing the tetrameric
DsRed2 protein were added in presence of CHX for 2 hours, a time sufficient to allow them to spread.
The two cell types were then PEG-fused, still in the presence of CHX, fixed one hour later and c-Fos
localization was analyzed by indirect immunofluorescence using the sc52 antibody and an FITC-
conjugated anti-rabbit antiserum. The dotted line delimits a red-fluorescing heterokaryon. Notably,
DsRed2 cannot enter the mouse nucleus during the course of the experiment due to its big size (4 x 28
kDa) and absence of NLS. The arrows indicate HeLa and Balb/C 3T3 nuclei with their easily
distinguishable Hoescht 33342 stainings. In (Ab), HeLa cells were cotransfected with plasmids for
DsRed2 and c-Fos for 16 hours before heterokaryon formation with asynchronously growing Balb/C
3T3 fibroblasts that do not express c-Fos. PEG-fusion and microscopic analysis were carried out as in
Aa. (B) FRAP analysis of HeLa cells homopolykaryons. HeLa cells were incubated with PEG for 1
min to induce homopolykaryon formation. One hour later, cells were co-transfected with vectors
expressing DsRed-monomer, a monomeric variant of DsRed that diffuses freely between the nucleus
and the cytoplasm, and either EGFP/c-Fos or GST/NLS/EGFP. 19 hours later, CHX was added and
one nucleus (open arrow) of each homopolykaryon was laser-photobleached. Recovery of
fluorescence was monitored for 2 hours with one acquisition every minute. In (Ba), the nucleus of an
isolated cell was also bleached (solid arrow). Absence of fluorescence recovery showed that protein
neosynthesis was efficiently inhibited by CHX. The rightmost and leftmost panels in Ba and Bb
present the merged DsRed2-monomer and EGFP fluorescences of the initial and final states,
respectively. The FRAP curves corresponding to (Ba) and (Bb) are presented in (Bc) and (Bd),
respectively. Blue and green curves correspond to fluorescence in the polykaryon bleached- and non-
bleached nuclei, respectively. The grey curve corresponds to the fluorescence of the bleached nucleus
of the isolated cell shown in (Ba). 5 independent FRAP experiments were carried out for each protein
with similar outcomes. (C) FLIP experiments on HeLa cells expressing GST/GFP/NLS and EGFP/c-
Fos. HeLa cells were co-transfected to express DsRed-monomer, which helps for the positioning of
the laser beam on the cytoplasm, and either GST/NLS/GFP or EGFP/c-Fos. FLIP experiments were
carried out 16 hours later after having, or not, stopped protein synthesis by CHX for 1 hour. To this
aim, cytoplasms were laser-irradiated every minute for 40 minutes and the remaining nuclear
fluorescence was measured after each bleach. Presented values correspond to the remaining nuclear
fluorescence after 40 minutes of FLIP calculated from the averages of 8 to 10 individual cells
analyzed in 3 independent transfections per experimental conditions. Error bars indicate standard
deviations.
Fig.  2 : Identification of the second c-Fos NLS. (A) Schematic structure of c-Fos. DNA binding
domain (DBD) and leucine zipper (LZ) are indicated. Numbers correspond to amino acid positions.
(B) Absence of NLS in the LZ and the C-terminal domain of c-Fos. HeLa cells were transfected with
expression vectors encoding the indicated c-Fos mutants and EGFP/c-Fos chimeras. 16 hours later,
the intracellular localization of the mutants was determined by indirect immunofluorescence using the
anti-c-Fos H125 rabbit antiserum and alexa488-conjugated anti-rabbit antiserum. Chimeras were
detected by direct fluorescence. (C) NLS activity is carried by the N-terminal domain of c-Fos. The
experiments were conducted as in B, except that observations were performed using a confocal
microscope. Each construct was analyzed in 3 to 6 independent transfection experiments. (D) Nuclear
versus cytoplasmic distribution of the constructs presented in C. Nuclear and cytoplasmic
fluorescences were quantified using the Metamorph software in 30 cells for each construct. The
histograms correspond to fluorescence percentages in the nucleus and in the cytoplasm with respect to
total cell fluorescence in the section analyzed.  Error bars indicate standard deviations.
Fig.  3 : TRN1 contributes to c-Fos nuclear import via the N-terminal NLS. (A) Cell
classification according to the cytoplasmic versus nuclear localization of c-Fos[1-139]/EGFP/GST.
HeLa cells were transfected to express c-Fos[1-139]/EGFP/GST. 16 hours later, fluorescence was
analyzed by confocal microscopy and the percentages of cytoplasmic and nuclear c-Fos[1-
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139]/EGFP/GST were quantified using the Metamorph software. Cells were classified in 3 groups
according to the fraction of c-Fos found in the cytoplasm, i.e. less than 30%, between 30 and 50% and
more that 50%. Figures representative of each group are presented. (B) Effect of anti-importin siRNAs
on the localization of c-Fos[1-139]/EGFP/GST. HeLa cells were transfected with the various siRNA
and, 36 hours later, with the c-Fos[1-139]/EGFP/GST. 16 hours later, at least 100 cells were analyzed
for classification as described in (A). Three independent experiments were conducted with similar
outcomes. (C) Immunoblotting characterization of siRNA effects. Extracts from cells transfected as in
(B) were analyzed by immunoblotting with the indicated anti-importin antisera. Exportin 7 was used
as an invariant control.
Fig. 4 : c-Fos shuttling is an active process and is not inhibited by leptomycin B. (A)
heterocaryon experiments in presence of LMB. Balb/C 3T3 fibroblasts were PEG-fused to HeLa cells
co-expressing DsRed2 protein and either EGFP-c-Fos, HA-tagged HADAC4 or GST/NLS/GFP/NES
after 1 hour pretreatment of both cell types with CHX and the indicated concentrations of LMB.
Heterokaryons were incubated at 37°C for 1 hour in the presence of the two drugs and then fixed.
HDAC4 was detected by indirect immunofluorescence with the 3F10 anti-HA rat monoclonal
antibody and Alexa488-conjugated anti-rat antiserum. EGFP chimeras were detected by direct
fluorescence. (B) c-Fos shuttling efficiency assayed in heterokaryons at low temperature. Hela cells
expressing dsRed2 and either EGFP/NLS/NLS or c-Fos were PEG-fused to Balb/C 3T3 cells. Fifteen
minutes after fusion, they were either maintained at 37°C (Control condition. Not shown. See text) or
placed on ice for 45 minutes to inhibit active nuclear import and export. c-Fos was detected using the
sc-52 goat antibody and an Alexa488-labelled anti-goat antiserum. Typical results are presented for
both c-Fos and EGFP/NLS/NLS. (C) c-Fos distribution at low temperature.  HeLa cells transfected
with plasmids encoding either EGFP/NLS/NLS or c-Fos were incubated on ice for 1 h before fixing
and microscope analysis. c-Fos was detected as in B. The percentage of cells with a strickly nuclear
localization or with a cytoplasmic redistribution is indicated. More than 300 cells were counted for
each transgene.
Fig. 5 : Dimerization with c-Jun inhibits c-Fos shuttling. (A) c-Fos heterodimerizes with c-Jun
upon co-transfection. HeLa cells were co-transfected with equivalent amounts of plasmids encoding
c-Fos and/or c-Jun C-terminally-tagged with the Flag epitope. 16 hours post-transfection,
immunoprecipitation was carried out using the anti-Flag M2 monoclonal antibody coupled to agarose
beads. Immunoblots of the 3 fractions (T : total cell extract, SN : supernatant, IP : immunoprecipitate)
corresponding to the same initial volume of extract were probed with the sc52 anti-c-Fos or sc45 anti-
c-Jun rabbit antisera. (B) Heterokaryon assays. HeLa cells were co-transfected with plasmids for
DsRed2 and either c-Fos, c-Jun or c-Fos + c-Jun. 16 hours later, they were PEG-fused with Balb/C
3T3 fibroblasts. c-Fos and c-Jun protein shuttling was assayed 1 hour post-fusion. c-Fos was detected
using the sc52 goat antibody and an Alexa488-labelled anti-goat antiserum whereas c-Jun was
detected with the sc45 rabbit antibody and an Alexa647-labelled anti-rabbit antiserum. The emission
spectra of the two dyes are sufficiently different to avoid any signal cross-contamination. The
shuttling efficiency was determined as in Fig 4C. Hatched histograms correspond to quantification of
c-Fos Alexa488 signals whereas dotted ones correspond to quantification of c-Jun Alexa647 signals.
The presented values are the average of values obtained from at least 20 heterokaryons per
experimental condition. The bars correspond to standard deviations. Three independent experiments
were conducted with similar outcomes. C) FLIP analysis. The shuttling of c-Fos in presence of c-Jun
was monitored by FLIP under the same conditions as in Fig. 1D. Ten FLIP experiments were carried
out. Typical curves of nuclear fluorescence decrease as a function of time are presented in the left
panel. The histograms in the right panel give the values of the remaining nuclear fluorescence after 40
minutes of FLIP. Error bars correspond to standard deviations. The presented data were obtained in
the absence of CHX. Similar results were obtained in its presence. (D) FRAP analysis. FRAP
experiments in c-Fos-expressing HeLa cells were carried out as described in Fig. 1B in the absence
(upper panels) or in the presence (lower panels) of c-Jun. An arrow indicates the bleached nucleus in
each HeLa homopolykaryon.  (E to H) Shuttling efficiencies of c-Fos and c-Jun mutants. Shuttling
efficiencies were assayed in heterokaryon assays as in (B). Hatched histograms correspond to c-Fos
shuttling analysis and dotted ones to c-Jun shuttling analysis. (E) corresponds to comparison of wild
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type c-Fos with the non-dimerizable c-FosVAV mutant in the presence and in the absence of c-Jun.
(F) corresponds to the comparison of wild type c-Jun with the non-dimerizable c-JunDLZ mutant in
the presence and in the absence of c-Fos. (G) corresponds to the comparison of c-Fos with the
tethered c-Jun~c-Fos dimer. Analysis of the localization of the latter was performed with both anti-c-
Fos and anti-c-Jun antibodies. (H) corresponds to the comparison of wild type c-Fos with the non
DNA-binding c-FosVV mutant in the presence and in the absence of c-Jun. (I) heterodimeric c-Fos is
associated with a non-soluble nuclear fraction. Fractionation experiments were carried out as
described in Materials and Methods in the presence of Triton X100 (also see Text) using
asynchronous transiently transfected HeLa cells expressing c-Fos either in absence or in presence of
c-Jun. Topoisomerase 1 and Phax were used as markers of the non soluble and soluble fractions
respectively (S = cytoplasmic and soluble nuclear proteins, W = wash fraction containing protein
loosely attached to chromatin and nuclear matrix, P = insoluble proteins of the chromatin- and the
nuclear matrix).
Fig. 6 : Heterodimerization inhibits c-Fos shuttling during the G0/G1 transition. (A) Expression
vectors recapitulating the transient serum-induced expression of c-fos gene. cDNA for EGFP-c-Fos
or EGFP-c-Fos∆LZ were cloned in a vector recapitulating the transient expression of the c-fos gene in
normal cells during the G0/G1 phase transition upon stimulation by serum owing to both a minimal c-
fos gene promoter containing the serum-responsive element and the c-fos mRNA 3'UTR. (B) Typical
heterokaryon assays using mouse cells traversing the G0/G1 phase transition. Serum starved c-fos-/-
f10 cells stably transfected with the plasmids described in A were stimulated by serum for 1 hour.
They were then PEG-fused to asynchronous Hela cells and fixed 1 hour later for microscopic
observation. (C) Shuttling efficiencies of EGFP-c-Fos and EGFP-c-Fos∆LZ. Fluorescence in the
donor and acceptor nuclei was measured as described in Fig. 4B on more than 50 heterokaryons in
each case.
Fig. 7 : Differential inhibition of c-Fos shuttling by Jun family members. (A) Relative shuttling
efficiencies of c-Fos, c-Jun, JunB and JunD transfected alone in heterokaryon assays. Experiments
were carried out as in Fig. 1B using HeLa cells as donors and Balb/C 3T3 cells as acceptors and
quantification were carried out as in Fig. 5A. c-Fos, c-Jun, JunB and JunD were detected using the
goat sc52G, rabbit sc45, the goat sc46G and rabbit sc74 antibodies, respectively, and anti-goat or anti-
rabbit Alexa488-conjugated secondary antibodies. (B) Inhibition of c-Fos shuttling by Jun proteins in
standard heterokaryon assays. Experiments were conducted as in Fig. 5B. c-Fos was detected using
the sc52 goat antibody and an Alexa488-labelled anti-goat secondary antibody. c-Jun, JunB and JunD
were detected with the sc-45, sc-46G and sc-74 antibodies, respectively, and Alexa 647-labelled anti-
rabbit antibodies. (C) Heterodimerization of c-Fos with Jun family members.  HeLa cells were co-
transfected with equivalent amounts of plasmids encoding c-Fos and either c-Jun, JunB or JunD. All
Juns were C-terminally tagged with the Flag epitope. Immunoprecipitations and immunoblots were
performed as described in Fig. 5A. (D) Inhibition of c-Fos shuttling by JunB or c-Jun in BiFC assay.
HeLa cells were transfected to express DsRed2 in the presence of either YFP[1-154]/c-Fos and
YFP[155-238]/JunB (upper panels) or YFP[1-154]/c-Fos and YFP[155-238]/c-Jun (lower panel) and
PEG-fused to Balb/C fibroblasts 24 hours later. Localization of YFP fluorescence-emitting dimers
was assayed 1 hour later after fixation and Hoescht 33342 nucleus staining.
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